Formycon AG (FYB) NPV

Sell:€22.35Buy:€22.60€0.20 (0.88%)

Prices delayed by at least 15 minutes
Sell:€22.35
Buy:€22.60
Change:€0.20 (0.88%)
Deal now
Prices delayed by at least 15 minutes
Sell:€22.35
Buy:€22.60
Change:€0.20 (0.88%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.

Key people

Wolfgang Essler
Chairman of the Supervisory Board
Stefan Glombitza
Chief Executive Officer, Member of the Executive Board
Colin Bond
Independent Deputy Chairman of Supervisory Board
Enno Spillner
Chief Financial Officer, Member of the Executive Board
Andreas Seidl
Chief Scientific Officer, Member of the Executive Board
Nicola Mikulcik
Member of the Executive Board, Chief Business Officer
Bodo Coldewey
Independent Member of the Supervisory Board
Nicholas Robert Haggar
Independent Member of the Supervisory Board
Klaus Roehrig
Member of the Supervisory Board
Click to see more

Key facts

  • Shares in issue
    17.67m
  • EPIC
    FYB
  • ISIN
    DE000A1EWVY8
  • Location
    Germany
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    €399.41m
  • Employees
    245
  • Exchange
    XETRA
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.